MY122779A - Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition. - Google Patents
Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition.Info
- Publication number
- MY122779A MY122779A MYPI20022316A MYPI20022316A MY122779A MY 122779 A MY122779 A MY 122779A MY PI20022316 A MYPI20022316 A MY PI20022316A MY PI20022316 A MYPI20022316 A MY PI20022316A MY 122779 A MY122779 A MY 122779A
- Authority
- MY
- Malaysia
- Prior art keywords
- preparing
- pharmaceutical composition
- processes
- anticholinergic
- crystalline
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 230000001078 anti-cholinergic effect Effects 0.000 title abstract 2
- VTTKBFMNVGIDQJ-UHFFFAOYSA-N nonane;hydrobromide Chemical compound Br.CCCCCCCCC VTTKBFMNVGIDQJ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
THE INVENTION RELATES TO CRYSTALLINE ANHYDROUS (1(ALPHA),2?,4?,5(ALPHA),7?)-7-[(HYDROXYDI-2-THIENYLACETLY)OXY]-9,9- DIMETHYL-3-OXA-9-AZONIATRICYCLO[3.3.1.0?,4] NONANE-BROMIDE, PROCESSES FOR PREAPRING IT AND ITS USE FOR PREPARING A PHARMACEUTICAL COMPOSITION, PARTICULARLY FOR PREPARING A PHARMACEUTICAL COMPOSITION WITH AN ANTICHOLINERGIC ACTIVITY.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10129710 | 2001-06-22 | ||
| DE10215436 | 2002-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY122779A true MY122779A (en) | 2006-05-31 |
Family
ID=26009556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20022316A MY122779A (en) | 2001-06-22 | 2002-06-20 | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition. |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP1401445B1 (en) |
| JP (1) | JP2005504015A (en) |
| KR (2) | KR100971616B1 (en) |
| CN (1) | CN100586948C (en) |
| AR (1) | AR037491A1 (en) |
| AT (1) | ATE337006T1 (en) |
| AU (1) | AU2002345016B2 (en) |
| BG (1) | BG66303B1 (en) |
| BR (1) | BR0210537A (en) |
| CA (1) | CA2450961C (en) |
| CO (1) | CO5550423A2 (en) |
| CY (1) | CY1105223T1 (en) |
| CZ (1) | CZ302786B6 (en) |
| DE (1) | DE50207943D1 (en) |
| DK (1) | DK1401445T3 (en) |
| EA (1) | EA005813B1 (en) |
| EE (1) | EE05316B1 (en) |
| EG (1) | EG24851A (en) |
| ES (1) | ES2271280T3 (en) |
| HR (1) | HRP20031066B1 (en) |
| HU (1) | HUP0400333A3 (en) |
| IL (2) | IL159238A0 (en) |
| ME (1) | ME00412B (en) |
| MX (1) | MXPA03011718A (en) |
| MY (1) | MY122779A (en) |
| NO (1) | NO334301B1 (en) |
| NZ (1) | NZ530690A (en) |
| PE (2) | PE20081305A1 (en) |
| PL (1) | PL208137B1 (en) |
| PT (1) | PT1401445E (en) |
| RS (1) | RS50441B (en) |
| SA (1) | SA02230255B1 (en) |
| SI (1) | SI1401445T1 (en) |
| SK (1) | SK287262B6 (en) |
| TW (2) | TWI261589B (en) |
| UY (1) | UY27342A1 (en) |
| WO (1) | WO2003000265A1 (en) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10212264A1 (en) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US20050038004A1 (en) * | 2003-07-31 | 2005-02-17 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| KR101285571B1 (en) * | 2003-11-03 | 2013-07-15 | 베링거 인겔하임 인터내셔날 게엠베하 | Novel crystalline anhydrate with anticholinergic effect |
| DE102004016179A1 (en) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Compounds for the treatment of proliferative processes |
| PT1781298E (en) | 2004-04-22 | 2012-02-03 | Boehringer Ingelheim Int | PHARMACEUTICAL COMBINATIONS CONTAINING BENZOXAZINS FOR THE TREATMENT OF RESPIRATORY DISEASES |
| DE102004024454A1 (en) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE602004020337D1 (en) | 2004-08-11 | 2009-05-14 | Boehringer Ingelheim Pharma | Anticholinergic drugs for the treatment of urinary tract disorders |
| US20060079544A1 (en) * | 2004-08-13 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
| DE102004048389A1 (en) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modification of surfaces of lactose as adjuvant for use with powder inhalants |
| CN101163706A (en) | 2005-04-21 | 2008-04-16 | 贝林格尔·英格海姆国际有限公司 | Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| KR20080007645A (en) | 2005-04-28 | 2008-01-22 | 베링거 인겔하임 인터내셔날 게엠베하 | New Compounds for Inflammatory Diseases |
| AU2006243239A1 (en) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Crystalline forms of tiotropium bromide |
| DK1881980T3 (en) * | 2005-05-02 | 2012-10-01 | Boehringer Ingelheim Int | New crystalline forms of tiotropium bromide |
| DE102005030733A1 (en) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient |
| WO2007020227A1 (en) | 2005-08-15 | 2007-02-22 | Boehringer Ingelheim International Gmbh | Method for producing betamimetics |
| TWI396541B (en) | 2005-10-10 | 2013-05-21 | Boehringer Ingelheim Int | Novel combinations of medicaments for the treatment of respiratory diseases |
| US7423146B2 (en) | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| JP5086267B2 (en) * | 2005-12-19 | 2012-11-28 | シコール インコーポレイティド | Novel form of tiotropium bromide and process for producing it |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| CN100999521B (en) * | 2006-01-13 | 2010-12-08 | 江苏正大天晴药业股份有限公司 | Crystal anti-choline medicine thiatropic bromoammonium |
| EP1847543A1 (en) | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| WO2008017637A1 (en) | 2006-08-07 | 2008-02-14 | Boehringer Ingelheim International Gmbh | Drug combinations for the treatment of respiratory tract diseases |
| UY30550A1 (en) | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | NEW BETA-AGANISTAS ENANTIOMÉRICAMENTE PUROS, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS |
| GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| MY153979A (en) | 2007-10-19 | 2015-04-30 | Boehringer Ingelheim Int | Substituted piperidino-dihydrothienopyrimidine |
| EP2093219A1 (en) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Crystalline enantiomer free salt form of a betamimetic and its use as medicine |
| CN102256963B (en) | 2008-12-19 | 2014-06-11 | 贝林格尔.英格海姆国际有限公司 | Cyclic pyrimidine-4-carboxamides as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD |
| WO2010101538A2 (en) | 2009-03-06 | 2010-09-10 | Bilgic Mahmut | New crystal forms |
| US20130143905A1 (en) | 2009-12-17 | 2013-06-06 | Boehringer Ingelheim International Gmbh | Novel antagonists for ccr2 and uses thereof |
| PT2513093E (en) | 2009-12-17 | 2014-10-22 | Boehringer Ingelheim Int | NEW CCR2 RECEIVER ANTAGONISTS AND THEIR USES |
| CN102822172A (en) | 2010-01-29 | 2012-12-12 | 贝林格尔.英格海姆国际有限公司 | Substituted naphthyridines and their use as syk kinase inhibitors |
| US8946218B2 (en) | 2010-05-12 | 2015-02-03 | Boehringer Ingelheim International Gmbh | CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| EP2569298B1 (en) | 2010-05-12 | 2015-11-25 | Boehringer Ingelheim International GmbH | Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| JP5647339B2 (en) | 2010-05-17 | 2014-12-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | CCR2 antagonists and uses thereof |
| JP5636094B2 (en) | 2010-05-25 | 2014-12-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | CCR2 receptor antagonist |
| US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
| TR201007108A2 (en) * | 2010-08-25 | 2012-03-21 | B�Lg�� Mahmut | New tiotropium bromide crystal and production method. |
| EP2668177B1 (en) | 2011-01-28 | 2014-10-22 | Boehringer Ingelheim International GmbH | Substituted pyridinyl-pyrimidines and their use as medicaments |
| TR201101897A2 (en) | 2011-02-28 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Crystal material containing tiotropium bromide |
| TR201102068A2 (en) | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Crystalline substances containing tiotropium bromide |
| TR201111589A2 (en) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropium bromide anhydrous crystal form. |
| EP2721025B1 (en) | 2011-06-16 | 2015-11-25 | Boehringer Ingelheim International Gmbh | New selective ccr2 antagonists |
| JP5786258B2 (en) | 2011-07-15 | 2015-09-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel and selective CCR2 antagonist |
| MX336224B (en) | 2011-07-26 | 2016-01-12 | Boehringer Ingelheim Int | Substituted quinolines and their use as medicaments. |
| US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| LT3421470T (en) | 2011-11-25 | 2021-04-26 | Adverio Pharma Gmbh | Substituted 5-fluoro-1h-pyrazolopyridines in crystalline form |
| CZ304368B6 (en) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Tiotropium bromide mixed solvate and process for preparing thereof |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (en) * | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | PROCESS FOR THE PREPARATION OF TIOTROPE BROMIDE |
| US9096579B2 (en) | 2012-04-20 | 2015-08-04 | Boehringer Ingelheim International Gmbh | Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| SI2914593T1 (en) | 2012-11-05 | 2017-05-31 | Zentiva, K.S. | Stabilization of tiotropium solvates |
| CN104341412A (en) * | 2013-07-29 | 2015-02-11 | 天津金耀集团有限公司 | Anhydrous tiotropium bromide crystal preparation method |
| JP6535022B2 (en) | 2014-03-19 | 2019-06-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Heteroaryl SYK inhibitors |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| SG11201702980QA (en) | 2014-10-21 | 2017-05-30 | Ariad Pharma Inc | Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine |
| WO2017138896A1 (en) * | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
| CA2425539C (en) * | 2000-10-12 | 2007-04-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition |
| DE10064816A1 (en) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Production of tiotropium bromide useful as an anticholinergic comprises oxidation of di-(2-thienyl)-glycolic acid tropenol ester and subsequent quaternisation |
-
2002
- 2002-06-08 HU HU0400333A patent/HUP0400333A3/en unknown
- 2002-06-08 AT AT02743165T patent/ATE337006T1/en active
- 2002-06-08 SI SI200230431T patent/SI1401445T1/en unknown
- 2002-06-08 SK SK52-2004A patent/SK287262B6/en unknown
- 2002-06-08 EP EP02743165A patent/EP1401445B1/en not_active Expired - Lifetime
- 2002-06-08 BR BR0210537-3A patent/BR0210537A/en not_active Application Discontinuation
- 2002-06-08 PT PT02743165T patent/PT1401445E/en unknown
- 2002-06-08 MX MXPA03011718A patent/MXPA03011718A/en active IP Right Grant
- 2002-06-08 DE DE50207943T patent/DE50207943D1/en not_active Expired - Lifetime
- 2002-06-08 CZ CZ20040120A patent/CZ302786B6/en not_active IP Right Cessation
- 2002-06-08 PL PL364489A patent/PL208137B1/en unknown
- 2002-06-08 AU AU2002345016A patent/AU2002345016B2/en not_active Expired
- 2002-06-08 WO PCT/EP2002/006291 patent/WO2003000265A1/en not_active Ceased
- 2002-06-08 KR KR1020037016769A patent/KR100971616B1/en not_active Expired - Lifetime
- 2002-06-08 NZ NZ530690A patent/NZ530690A/en not_active IP Right Cessation
- 2002-06-08 HR HR20031066A patent/HRP20031066B1/en not_active IP Right Cessation
- 2002-06-08 DK DK02743165T patent/DK1401445T3/en active
- 2002-06-08 CN CN02812303A patent/CN100586948C/en not_active Expired - Lifetime
- 2002-06-08 JP JP2003506910A patent/JP2005504015A/en active Pending
- 2002-06-08 RS YUP-997/03A patent/RS50441B/en unknown
- 2002-06-08 IL IL15923802A patent/IL159238A0/en unknown
- 2002-06-08 KR KR1020097004823A patent/KR101011353B1/en not_active Expired - Lifetime
- 2002-06-08 CA CA2450961A patent/CA2450961C/en not_active Expired - Fee Related
- 2002-06-08 EA EA200301293A patent/EA005813B1/en not_active IP Right Cessation
- 2002-06-08 ME MEP-2008-620A patent/ME00412B/en unknown
- 2002-06-08 ES ES02743165T patent/ES2271280T3/en not_active Expired - Lifetime
- 2002-06-08 EE EEP200400029A patent/EE05316B1/en unknown
- 2002-06-19 TW TW091113373A patent/TWI261589B/en not_active IP Right Cessation
- 2002-06-19 EG EG2002060698A patent/EG24851A/en active
- 2002-06-19 TW TW095100968A patent/TW200617007A/en unknown
- 2002-06-20 MY MYPI20022316A patent/MY122779A/en unknown
- 2002-06-20 UY UY27342A patent/UY27342A1/en not_active Application Discontinuation
- 2002-06-21 PE PE2007000660A patent/PE20081305A1/en not_active Application Discontinuation
- 2002-06-21 PE PE2002000538A patent/PE20030130A1/en active IP Right Grant
- 2002-06-21 AR ARP020102337A patent/AR037491A1/en not_active Application Discontinuation
- 2002-08-19 SA SA2230255A patent/SA02230255B1/en unknown
-
2003
- 2003-12-08 IL IL159238A patent/IL159238A/en active IP Right Grant
- 2003-12-12 BG BG108440A patent/BG66303B1/en unknown
- 2003-12-19 NO NO20035696A patent/NO334301B1/en not_active IP Right Cessation
-
2004
- 2004-01-20 CO CO04003764A patent/CO5550423A2/en not_active Application Discontinuation
-
2006
- 2006-09-20 CY CY20061101339T patent/CY1105223T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY122779A (en) | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition. | |
| CA2425539A1 (en) | Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition | |
| MY139720A (en) | Micronized crystalline tiotropium bromide | |
| AU6973991A (en) | Therapeutically active chloro substituted benzimidazoles, processes for their preparation as well as their use | |
| YU50903A (en) | Method for producing the anticholinergic agent tiotropium bromide | |
| GEP20074099B (en) | 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
| IL157940A0 (en) | Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient | |
| IL142768A0 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
| AU2002210952A1 (en) | Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist | |
| MY125978A (en) | Admantane derivatives | |
| IL198285A (en) | Process for the measurement of the potency of glatiramer acetate | |
| AU2003206760A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
| GB0109122D0 (en) | Novel compounds | |
| HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
| IL101358A0 (en) | Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it | |
| AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
| GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| GR1004358B (en) | Anhydrous crystalline valaciclivier hydrochloride | |
| CA2163118A1 (en) | Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use | |
| WO2003024933A1 (en) | 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same | |
| TW200630100A (en) | Formulations of [1,4]diazepino[6,7,1- ij]quinoline derivatives | |
| GB9907001D0 (en) | Gps for workstations | |
| ECSP045321A (en) | FORMULATIONS IN SUSPENSION WITH HFA CONTAINING AN ANTICHOLINERGIC | |
| AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
| MY138088A (en) | Use of deoxypeganine for treating clinical depression |